The hematologic manifestations of the antiphospholipid syndrome

Blood Reviews
Imad UthmanMunther A Khamashta

Abstract

Various hematological pathologies have been described in association with antiphospholipid syndrome (APS). Thrombocytopenia is frequently found in APS patients, its incidence has ranged from 22-42% in different series, it is usually moderate (>50x10(9)/L) without clinical manifestation and requires no intervention. A high percentage of patients with isolated idiopathic thrombocytopenic purpura have antiphospholipid antibodies, however the pathogenetic role and the clinical importance of these antibodies in this condition is still not clear. Other hematological manifestations reported in association with APS include: bone marrow necrosis, and various thrombotic microangiopathic syndromes such as: thrombotic thrombocytopenic purpura, hemolytic-uremic syndrome, HELLP (hemolysis, elevated liver enzymes, low platelet) syndrome, and catastrophic APS. A high index of suspicion is needed for the early recognition and treatment of these conditions.

References

Aug 1, 1991·Annals of the Rheumatic Diseases·H J OutR H Derksen
Oct 11, 1986·British Medical Journal·S Fairley, B U Ihle
Oct 1, 1988·Annals of the Rheumatic Diseases·M A KhamashtaG R Hughes
Dec 1, 1987·Arthritis and Rheumatism·S StudenskiR P Polisson
Jul 1, 1985·American Journal of Hematology·D A GastineauE J Bowie
Feb 1, 1985·British Journal of Haematology·E N HarrisG R Hughes
Sep 1, 1983·Medicine·M H MillerD W Killinger
May 1, 1984·Nihon rinsho. Japanese journal of clinical medicine·T Ofuji
Aug 1, 1993·American Journal of Hematology·Z M SthoegerA Berrebi
May 15, 1995·Annals of Internal Medicine·P LespritB Wechsler
Jun 1, 1995·The American Journal of Medicine·S BulvikP Jacobs
Dec 1, 1994·Seminars in Arthritis and Rheumatism·R JainR Furie
Mar 1, 1993·Clinical Immunology and Immunopathology·N S RoteR Siekman
Apr 1, 1996·British Journal of Haematology·M GalliT Barbui
Dec 1, 1996·Clinical Immunology and Immunopathology·J FontM Ingelmo
Mar 1, 1997·Annals of the Rheumatic Diseases·M J CuadradoG R Hughes
Mar 1, 1997·Journal of Clinical Pathology·S PaydasF Baslamisli
Aug 26, 1998·Journal of Clinical Pathology·P T MurphyJ K Wood
Oct 14, 1998·Pathology·J MooreA Concannon
Nov 30, 1999·Annals of Internal Medicine·J C PietteA Foucher-Lavergne
Mar 21, 2000·The American Journal of Medicine·S I KokoriH M Moutsopoulos
Jan 5, 2002·American Journal of Hematology·C AlliotM Barrios
Jan 15, 2002·Lupus·R CerveraUNKNOWN European Working Party on Systemic Lupus Erythematosus
Mar 1, 2002·European Radiology·Christina ThuerlJörg Laubenberger
Mar 6, 2002·Clinical and Experimental Immunology·A Faber-ElmannE Mozes
Apr 16, 2002·Arthritis and Rheumatism·Ricard CerveraUNKNOWN Euro-Phospholipid Project Group
Feb 18, 2003·British Journal of Haematology·UNKNOWN British Committee for Standards in Haematology General Haematology Task Force

❮ Previous
Next ❯

Citations

Aug 25, 2009·Rheumatology International·Lama BazziImad Uthman
Dec 17, 2009·Hematology·Wendy Lim
Sep 19, 2012·Asian Journal of Transfusion Science·Laura ScaramucciPaolo de Fabritiis
Apr 20, 2011·Current Rheumatology Reports·Alana B Levine, Doruk Erkan
Mar 20, 2012·Best Practice & Research. Clinical Rheumatology·Mara TaraborelliAngela Tincani
May 9, 2012·Immunobiology·Dragana Popovic-KuzmanovicVladimir Trajkovic
Nov 26, 2009·Hematology/oncology Clinics of North America·Daniel G Arkfeld, Ilene C Weitz
Jul 23, 2008·La Presse médicale·Bertrand Godeau, Philippe Bierling
Apr 17, 2016·International Journal of Hematology·Wendy J LangebergScott Stryker
Oct 1, 2011·Platelets·Jose Ignacio Ruades NinfeaJuan Jose Garcia
Feb 8, 2011·La Revue de médecine interne·S JosseV Queyrel
Jun 24, 2016·Clinical and Experimental Medicine·Simone NegriniFrancesco Puppo
Feb 6, 2017·Medicina clínica·Rosalia Demetrio PabloVictor Manuel Martínez-Taboada
Feb 23, 2017·Coronary Artery Disease·Salik NazirAnthony Donato
Jul 26, 2017·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Chandrahasa Annem, Richard A Furie
May 17, 2014·The Journal of Rheumatology·Bahar Artim-EsenMurat Inanç
Sep 13, 2018·VASA. Zeitschrift für Gefässkrankheiten·Birgit Linnemann
Jul 5, 2019·The Medical Journal of Australia·Veronica MezhovFlavia M Cicuttini
Apr 3, 2010·Clinical Chemistry·Katrien Devreese, Marc F Hoylaerts
Apr 25, 2012·Hematology·Ricardo Forastiero
Dec 20, 2019·Annals of Hematology·Shoko ItoYoshinobu Kanda
Jan 10, 2018·Journal of Thrombosis and Haemostasis : JTH·E PontaraV Pengo
Jul 24, 2020·Current Rheumatology Reports·Eleni Xourgia, Maria G Tektonidou
Oct 12, 2018·Case Reports in Rheumatology·Omar Tolaymat, Florentina Berianu
Jul 28, 2020·La Revue de médecine interne·M EbboB Godeau
Feb 9, 2021·Movement Disorders Clinical Practice·Roshni Abee PatelMeagan Bailey
Apr 7, 2021·British Journal of Haematology·Dawn SwanJecko Thachil
May 11, 2021·Modern Rheumatology Case Reports·Amaya Llorente-ChávezJavier Merayo-Chalico

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Polyendocrinopathies

Autoimmune polyendocrinopathies, also called polyglandular autoimmune syndromes (PGASs), or polyendocrine autoimmune syndromes(PASs), are a heterogeneous group of rare diseases characterized by autoimmune activity against more than one endocrine organ, although non-endocrine organs can be affected. Discover the latest research on autoimmune polyendocrinopathies here.

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.

Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) occurs when antibodies directed against the person's own red blood cells (RBCs) cause them to burst (lyse), leading to an insufficient number of oxygen-carrying red blood cells in the circulation. Discover the latest research on AIHA here.

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.